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TO THE EDITOR
Neurofibromatosis type 1 (NF1), a
common autosomal dominant disorder
caused by mutations in the NF1 gene, is
characterized by presence of neuro-
fibromas, skin-fold freckling, cafe´ au
lait macules (CALMs) and iris Lisch
nodules. So far, little is known about
the etiopathogenesis of NF1-related
CALMs. The NF1 gene, like other tumor
suppressor genes, follows the Knudson
two-hit hypothesis of tumor formation,
implying that, apart from the germline
NF1 mutation, an additional somatic
inactivation of the remaining wild-type
NF1 allele is needed to initiate tumor
formation (Knudson, 1971). In general,
somatic inactivation of a tumor sup-
pressor gene can occur via three major
mechanisms: loss of heterozygosity
(LOH), somatic intragenic mutations,
and promoter hypermethylation. One
study addressed somaticNF1 inactivation
in 11 CALM melanocyte cultures and
found both NF1 alleles to be present
(Eisenbarth et al., 1997). However, this
study only searched for LOH, and not for
minor lesion somatic mutations.
Therefore, we now performed a
comprehensive search for NF1 somatic
alterations in melanocytes, keratino-
cytes, and fibroblasts obtained from
NF1 CALMs, allowing identification of
LOH, copy-number changes of one to
multiple exons, and minor lesion muta-
tions. Three keratinocyte, 11 fibroblast
and five melanocyte CALM-derived
primary cell cultures of 13 patients with
a known germline NF1 mutation were
examined, in addition to six melano-
cyte cultures from neonatal foreskin of
healthy control persons.
Patients were diagnosed according
to the NIH diagnostic criteria. Skin
biopsies from NF1 CALMs were taken
after written informed consent, and guided
by the institutional ethics committee and
the Declaration of Helsinki Principles.
Skin biopsies and cell cultures were
performed essentially as described in
De Schepper et al. (2006).
For genomic DNA (gDNA) extraction
(QiaAmp, Belelux, Spoorstraat, Venlo, The
Netherlands) or Gentra Puregene (Qiagen,
Venlo, The Netherlands), RNA isolation
(Rneasy; Qiagen), and cDNA synthesis
(iScript; BioRad) the manufacturer’s in-
structions were followed.
LOH in the NF1 gene region was
evaluated by genotyping two telomeric
microsatellite markers and four within
the NF1 gene as described previously
(Wimmer et al., 2006). Primer se-
quences can be found in Table 1.
Fragments for all loci were compared
between DNA extracted from periph-
eral blood leukocytes from each
patient and the CALM derived cell
cultures.
NF1 gene somatic mutation analysis
was performed essentially as described
in Vandenbroucke et al. (2004). All
mutations found at the cDNA level
were confirmed on gDNA. If no so-
matic hit was detected after sequencing
of the entire coding region, multiplex
ligation probe assay analysis using the
P081/P082 assay (MRC Holland) was
performed as described (Wimmer et al.,
2006). In order to determine whether
both NF1 mutations detected in mela-
nocyte cultures derived from the CALM
of patient NF-008 resided on different
alleles, cloning experiments were per-
formed using the pCR2.1-TOPO Vector
(Invitrogen, Merelbeke, Belgium).
LOH analysis
LOH analysis could not detect a so-
matic event in any of the investigated
samples. All patients displaying hetero-
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Table 1. Primers for microsatellite markers used in LOH analysis
Sequence Markers
CAAGAAAAGCTAATATCGGC AluI
GGAACCTTAAGTTCACTTAG
CTCCTAACATTTATTAACCTTA IVS38 GT53.0
CAGAGCAAGACCCTGTCT
CCCATACCTAGTTCTTAAAGTCTGT IVS27 AC33.1
TAACAATTGTGGAACTGCAGCAATTATT
CTGAAGCAGGAGAATTGC IVS27 TG24.8
CTAAAGATGTCTATAACAGGT
CTTCCATGGCTGCTAACATC 30 NF1-1
CCCTGTGGTGTAGTTCAACA
GGTGTGTGTATATGTGCGTG 30 NF1-3
GGTACAGCATATCCACAAGG
LOH, loss of heterozygosity; NF1, neurofibromatosis type 1.
Abbreviations: CALM, Cafe´ au lait macule; LOH, loss of heterozygosity; LR, long range;
NF1, neurofibromatosis type 1
zygosity for at least one microsatellite
marker in blood lymphocytes did not
show LOH in the CALM-derived cells
(fibroblasts, keratinocytes, and melano-
cytes) (Table 2). Since the six poly-
morphic markers span the NF1 gene,
this analysis excludes loss of the wild-
type NF1 allele in NF1-related CALMs.
Six normal skin melanocyte cultures
obtained from healthy controls and
cultured in exactly the same way as
the NF1 CALM melanocyte samples
were subjected to microsatellite marker
and multiplex ligation probe assay
analysis. Two NF1 copies were present
in all melanocyte cultures and no copy-
number changes were detected.
Long-range PCR and direct sequencing of
the entire NF1 coding region
The germline NF1 mutation was
confirmed to be present in the 11
CALM-derived fibroblast cultures, the
three keratinocyte cultures, and five
melanocyte cultures. In addition, an
additional NF1 mutation was identified
in all CALM-derived melanocyte cul-
tures. Three were nonsense mutations:
c.2269 A4T (p.K757X), c.4537 C4T
(p.R1513X), and c.3721C4T (p.R1241X).
One was a splice mutation (c.1721þ
542A4G), increasing the strength of a
cryptic splice donor site in intron 11,
that gets used in conjunction with a
cryptic intronic splice acceptor site,
leading to insertion of 176 bp from
intron 11 in the mature transcript.
Finally, one culture showed loss of
expression of the wild-type NF1 allele
Table 2. Summary of demographic patient data and results
NF1
patients
Sex and age
(years)
Cell
types
cultured Results LOH Results LR RT–PCR/direct sequencing
Alu IVS 38GT
53.0
IVS 27 TG
24.8
IVS 27 AC
33.1
30NF1-1 30NF1-3 Germline mutation Second hit mutation
NF-002 Male (53) FB NI H H H NI H c.1721+1G4A
(skipping exon 11)
None
NF-003 Male (48) FB NI H H H H NI c.3709-??_3974+?? del
(Deletion E22 &23.1)
None
NF-004 Female (37) FB NI H NI NI H NI c.2851-2A4G
(skipping
exon 17)
None
NF-006 Female (25) KC NI H NI H H NI c.4368-2A4G
(skipping
first 115 bp
from E26)
None
NF-007 Male (19) FB H H H H H NI c.3113+1G4A
(skipping E18)
None
NF-001 Female (36) KC NI NI NI H H NI c.2887C4T (p.Q963X) None
NF-012 Female (49) MC NI H H H H H c.1541_1542delAG c.3721C4T (p.R1241X)
KC NI H H H H H c.1541_1542delAG None
FB NI H H H H H c.1541_1542delAG None
NF-005 Female (46) FB NI H H H NI H c.5122_5123 insG None
NF-008 Female (49) FB c.3525_3526delAA None
MC c.3525_3526delAA c.2269A4T (p.K757X)
NF-010 Female (35) FB NI H NI NI H NI c.2681T4C (p.F894S) None
NF-011 Male (62) MC NI H NI NI H NI c.2681T4C (p.F894S) Loss of expression of
the WT allele ; WT allele
is present at the gDNA level
FB NI H NI NI H NI c.2681T4C (p.F894S) None
NF-013 Female (22) MC H H H H H H c.4537C4T (p.R1513X) c.1721+542 A4G
(splice mutation, leads
to insertion of 176 bp
from intron 11 in the
transcript)
FB H H H H H H c.4537C4T (p.R1513X) None
NF-014 Female (39) MC NI NI NI NI NI NI c.2492_2493delCA c.4537C4T (p.R1513X)
FB NI NI NI Ni Ni Ni c.2492_2493delCA None
FB, fibroblasts; H, heterozygous; KC, keratinocytes; LR, long range; MC, melanocytes; NF1, neurofibromatosis type 1; NI, not informative; RT–PCR, reverse
transcription–PCR.
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at the transcript level, however, no
second hit mutation could be identified.
The cause of the loss of expression of
the wild-type allele and/or allelic drop-
out is currently under further investiga-
tion. Two of the identified somatic
mutations (p.R1241X and p.R1513X)
have been reported previously as a
germline mutation (Fahsold et al.,
2000; Messiaen et al., 2000, Origone
et al., 2003; Upadhyaya et al., 2003).
Cloning experiments demonstrated that
for the CALM of patient NF-008
(c.3525_3526delAA and c.2269A4T),
both NF1mutations resided on different
alleles.
No NF1 gene mutations were de-
tected in the six melanocyte cultures
obtained from neonatal foreskin from
healthy controls using comprehensive
mutation analysis, and microsatellite
analysis showed presence of two NF1
copies.
The etiopathogenesis of neurofibro-
ma formation in NF1 mouse models
was recently ascribed to neurofibromin-
deficient Schwann cells (NF1/) se-
creting a potent migratory stimulus
(stem cell factor or Kit ligand) for
NF1þ / mast cells (Ingram et al.,
2000; Yang et al., 2003), implying a
somatic second hit mutation of the
NF1 gene in heterozygous Schwann
cells as the initiating event for the
development of a benign (plexiform)
neurofibroma.
This study wants to address whether
a similar mechanism, based on neuro-
fibromin deficiency due to a second hit
mutation, is also applicable for the NF1
CALMs. Several researchers have tried
to characterize CALMs histologically,
but with conflicting results (Kawamura,
1956; Benedict et al., 1968; Johnson
and Charneco, 1970; Takahashi, 1976;
Frenck and Marazzi, 1984; Ishida and
Jimbow, 1987; Grossman et al., 1995).
We recently demonstrated that the mel-
anocyte density is increased in NF1
CALM skin compared with NF1 normal
skin and healthy control CALM, and
normal skin (De Schepper et al., 2006).
In line with this study, an NF1
second hit in NF1 CALM melanocytes
was found in 5/5 available melanocyte
cultures, but not in the keratinocytes or
fibroblasts from these cafe´ au lait spots.
No NF1 mutations were found in the
melanocyte cultures from neonatal
foreskin from healthy control persons.
This study confirms and extends the
findings of a second hit mutation in
melanocyte cultures from a segmental
and mosaic NF patient (Maertens et al.,
2007). We conclude from our study that
there is a statistically significant differ-
ence (Po0.05) in the frequency of
second hit mutations in CALM melano-
cytes (5/5) compared with CALM fibro-
blasts (0/11) (P¼ 0.000, Fisher’s Exact
Test), and with CALM keratinocytes (0/
3) (P¼ 0.018, Fisher’s Exact Test). So far
no evidence points to a significant
contribution of LOH to CALM forma-
tion. Six healthy control normal skin
melanocyte cultures, which were ana-
lyzed as negative controls did not show
any somatic NF1 alterations.
The finding of second hit mutations
in NF1 CALM melanocytes improves
our understanding of the etiopatho-
genic mechanisms underlying the for-
mation of this hyperpigmentary
disorder, and will boost further research
aiming to understand the phenotypes
associated with somatic mutations in
melanocytes.
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